三门峡市那家医院治疗狐臭三门峡腋臭原因及治疗,三门峡医院那家狐臭做得好,三门峡嘴巴周围长痘痘,三门峡去除痤疮最快的办法,三门峡长痘痘要怎么办,三门峡腋臭手术哪里做的好,三门峡那里治狐臭的地方好

A lawsuit filed against the University of California system wants colleges to stop using SAT and ACT scores in the admissions process.The lawsuit was filed Tuesday on behalf of four students and several nonprofits. It claims standardized tests are discriminatory to people with disabilities, low-income students and minorities."These discriminatory tests irreparably taint UC’s ostensibly 'holistic' admissions process," the lawsuit states. "The mere presence of the discriminatory metric of SAT and ACT scores in the UC admissions process precludes admissions officers from according proper weight to meaningful criteria, such as academic achievement and personal qualities, and requires them instead to consider criteria that act as a proxy for wealth and race and thus concentrate privilege on UC campuses."Consequently, the UC admissions process — as deliberately operated by the Regents — creates formidable barriers to access to public higher education for deserving students from low-income families, students from historically underrepresented racial and ethnic groups, and students with disabilities. The requirement that all applicants submit SAT or ACT scores systematically and unlawfully denies talented and qualified students with less accumulated advantage a fair opportunity to pursue higher education at the UC."The University of California is the largest public university system in the U.S., with 10 campuses and more than 280,000 students.The UC system said in a statement it is disappointed by the lawsuit since its officials are already making efforts to address the concern. The College Board, which administers the SAT, was also quick to respond. It said any allegation of the test being discriminatory is wrong and it focuses on combating educational inequalities.Universities across the country typically use standardized tests in their admissions processes, but some are phasing them out. The full lawsuit can be read below or by clicking 1978

A million Powerball jackpot remains unclaimed 11 months after the drawing.The ticket matched the five white balls drawn - 15,29,31,37,43 - in the Dec. 19, 2018 drawing. The winning ticket was bought at the Marathon gas station located in Farmington Hills, Michigan.Tickets for Powerball are valid for one year from the drawing date. The winner is asked to contact the Michigan Lottery Public Relations Division at 517-373-1237 to collect the prize. 463

SEATTLE – Health officials in Washington state said Sunday night that a second person had died from the coronavirus and researchers said it may have been circulating for weeks undetected in the greater Seattle area. In a statement, 246

A jury in Ohio found Brooke Skylar Richardson not guilty of aggravated murder, involuntary manslaughter, and child endangerment on Thursday. Richardson was found guilty of abuse of a corpse. She will be sentenced on the one guilty count on Friday.Richardson, now age 20, was accused of killing her newborn daughter in 2017 and burying her in the backyard of her family's home.The jury had been deliberating since 11:11 a.m. Thursday after two hours of closing arguments, two days of defense testimony and four days or prosecution testimony. 553

Scientists are working to eliminate a type of heart disease in dogs using gene therapy. They're zoning in on a heart condition called mitral valve disease that’s common in 6% of dogs. Scientists are using Cavalier King Charles spaniels for the research. They tend to develop it at a younger age. Scientists at Tufts University have already tested gene therapy in mice. A virus is injected into them to deliver DNA to cells which causes them to create a protein. What it essentially does is stops the heart valve from getting thicker, stopping the valve from leaking. Researchers are now moving on to testing this in dogs. But they think the treatment could go beyond just canines. “Many of the dog diseases are naturally occurring and really great models for human disease,” says Dr. Vicky Yang, a veterinary cardiologist and research assistant professor at Cummings School of Veterinary Medicine at Tufts University. “And I can see this, if it becomes successful in dogs, potentially going into thinking about treatment for humans for mitral valve disease.”The biotech company behind the treatment agrees. It says it could also expand beyond heart problems. “I think a larger question, though, is if we are able to prove this thesis of treating aging, making the animal generally healthier, could also treat heart failure, what other diseases could we treat in dogs?” says Daniel Oliver, the CEO of Rejuvenate Bio. “And could we progress this treatment onto past dogs and other animals and possibly humans?” The gene therapy would only be used for dogs just starting to experience heart problems.Researchers still need to make sure the gene therapy is safe for all breeds before they make it available to the public. 1730